Gonorrhea resistance · surveillance reporting
A verified gonorrhea resistance update must separate laboratory surveillance from treatment guidance. Susceptibility patterns describe tested isolates; they do not diagnose an individual infection or authorize a newsroom to recommend therapy.
How CDC monitors resistance
CDC identifies several U.S. surveillance projects, including the Gonococcal Isolate Surveillance Project, enhanced GISP and Strengthening the United States Response to Resistant Gonorrhea. Antimicrobial susceptibility testing is common to those projects.
The agency explains that decreased susceptibility means laboratory testing found that higher-than-expected antimicrobial levels were needed to stop bacterial growth. That laboratory definition should not be replaced with the broader word “resistant” unless the selected source uses it for the same drug and threshold.
Trend reporting must also preserve changes in participating sites, specimen collection and laboratory standards. A different threshold or larger surveillance network can change the displayed proportion without representing the same underlying comparison.
Why the sample matters
CDC notes that resistance monitoring faces a laboratory challenge: nucleic acid amplification tests are widely used for diagnosis, but susceptibility testing generally requires culture. A surveillance set of cultured isolates can therefore differ from all diagnosed cases in who, where and what it represents.
A resistance surveillance release and CDC treatment guidance may be updated on different dates. Verify both, cite each for its own claim, and do not infer a regimen change from surveillance data alone.
A publication checklist
- Name the surveillance system and collection period.
- Identify specimen source, population and geography.
- State the antimicrobial and exact susceptibility definition.
- Report numerator, denominator and uncertainty where available.
- Check separately for a dated CDC guidance update.
What remains uncertain
This guide does not announce a future resistance event. Publication as news requires an exact CDC release and an independently dated guidance check. Readers with possible exposure or symptoms need confidential testing and care from qualified professionals; population surveillance cannot answer their diagnosis or treatment.